| Tahnee Siewert, | |
|
1650 S 41st St, Manitowoc, WI 54220-7316 | |
| (920) 320-4660 | |
| Not Available |
| Full Name | Tahnee Siewert |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 12 Years |
| Location | 1650 S 41st St, Manitowoc, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013265966 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 175038-30 (Wisconsin) | Secondary |
| 363LG0600X | Nurse Practitioner - Gerontology | 5173-33 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aspirus Wausau Hospital | Wausau, WI | Hospital |
| Aspirus Medford Hospital & Clinics, Inc | Medford, WI | Hospital |
| Langlade Hospital | Antigo, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aspirus Medical Group Inc | 1052223625 | 212 |
News Archive
The first randomized Phase II clinical trial to report on single and combined neoadjuvant immune checkpoint inhibitor therapy in stage I-III non-small cell lung cancer (NSCLC) found combination therapy produced a significant clinical benefit, as assessed by major pathologic response (MPR) rate, as well as enhanced tumor immune cell infiltration and immunological memory.
FDA has approved a combination of Hycamtin (topotecan hydrochloride) and cisplatin for use as the first drug treatment for women with late-stage cancer of the cervix.
Abbott will feature new solutions to improve data management and automation at this year's American Association for Clinical Chemistry (AACC) annual meeting, July 15-19, in Los Angeles, Calif. Solutions to further enhance efficiency and workflow in today's laboratories will be the focal point of the Abbott exhibit.
Among 96 former Swiss indentured child laborers, 22 individuals showed post-traumatic stress disorder (PTSD) symptoms and 53 reported having experienced childhood trauma. Men reported a significantly higher prevalence of both sexual concerns and dysfunctional sexual behavior compared with women.
› Verified 3 days ago
| Entity Name | Aspirus Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669595294 PECOS PAC ID: 1052223625 Enrollment ID: O20031103000267 |
News Archive
The first randomized Phase II clinical trial to report on single and combined neoadjuvant immune checkpoint inhibitor therapy in stage I-III non-small cell lung cancer (NSCLC) found combination therapy produced a significant clinical benefit, as assessed by major pathologic response (MPR) rate, as well as enhanced tumor immune cell infiltration and immunological memory.
FDA has approved a combination of Hycamtin (topotecan hydrochloride) and cisplatin for use as the first drug treatment for women with late-stage cancer of the cervix.
Abbott will feature new solutions to improve data management and automation at this year's American Association for Clinical Chemistry (AACC) annual meeting, July 15-19, in Los Angeles, Calif. Solutions to further enhance efficiency and workflow in today's laboratories will be the focal point of the Abbott exhibit.
Among 96 former Swiss indentured child laborers, 22 individuals showed post-traumatic stress disorder (PTSD) symptoms and 53 reported having experienced childhood trauma. Men reported a significantly higher prevalence of both sexual concerns and dysfunctional sexual behavior compared with women.
› Verified 3 days ago
| Entity Name | Aspirus Wausau Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922321140 PECOS PAC ID: 6406757442 Enrollment ID: O20040114000297 |
News Archive
The first randomized Phase II clinical trial to report on single and combined neoadjuvant immune checkpoint inhibitor therapy in stage I-III non-small cell lung cancer (NSCLC) found combination therapy produced a significant clinical benefit, as assessed by major pathologic response (MPR) rate, as well as enhanced tumor immune cell infiltration and immunological memory.
FDA has approved a combination of Hycamtin (topotecan hydrochloride) and cisplatin for use as the first drug treatment for women with late-stage cancer of the cervix.
Abbott will feature new solutions to improve data management and automation at this year's American Association for Clinical Chemistry (AACC) annual meeting, July 15-19, in Los Angeles, Calif. Solutions to further enhance efficiency and workflow in today's laboratories will be the focal point of the Abbott exhibit.
Among 96 former Swiss indentured child laborers, 22 individuals showed post-traumatic stress disorder (PTSD) symptoms and 53 reported having experienced childhood trauma. Men reported a significantly higher prevalence of both sexual concerns and dysfunctional sexual behavior compared with women.
› Verified 3 days ago
| Entity Name | Aspirus Medford Hospital & Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285703173 PECOS PAC ID: 5799688602 Enrollment ID: O20040129000007 |
News Archive
The first randomized Phase II clinical trial to report on single and combined neoadjuvant immune checkpoint inhibitor therapy in stage I-III non-small cell lung cancer (NSCLC) found combination therapy produced a significant clinical benefit, as assessed by major pathologic response (MPR) rate, as well as enhanced tumor immune cell infiltration and immunological memory.
FDA has approved a combination of Hycamtin (topotecan hydrochloride) and cisplatin for use as the first drug treatment for women with late-stage cancer of the cervix.
Abbott will feature new solutions to improve data management and automation at this year's American Association for Clinical Chemistry (AACC) annual meeting, July 15-19, in Los Angeles, Calif. Solutions to further enhance efficiency and workflow in today's laboratories will be the focal point of the Abbott exhibit.
Among 96 former Swiss indentured child laborers, 22 individuals showed post-traumatic stress disorder (PTSD) symptoms and 53 reported having experienced childhood trauma. Men reported a significantly higher prevalence of both sexual concerns and dysfunctional sexual behavior compared with women.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tahnee Siewert, 4540 S 16th St, Sheboygan, WI 53081-7718 Ph: (920) 634-9393 | Tahnee Siewert, 1650 S 41st St, Manitowoc, WI 54220-7316 Ph: (920) 320-4660 |
News Archive
The first randomized Phase II clinical trial to report on single and combined neoadjuvant immune checkpoint inhibitor therapy in stage I-III non-small cell lung cancer (NSCLC) found combination therapy produced a significant clinical benefit, as assessed by major pathologic response (MPR) rate, as well as enhanced tumor immune cell infiltration and immunological memory.
FDA has approved a combination of Hycamtin (topotecan hydrochloride) and cisplatin for use as the first drug treatment for women with late-stage cancer of the cervix.
Abbott will feature new solutions to improve data management and automation at this year's American Association for Clinical Chemistry (AACC) annual meeting, July 15-19, in Los Angeles, Calif. Solutions to further enhance efficiency and workflow in today's laboratories will be the focal point of the Abbott exhibit.
Among 96 former Swiss indentured child laborers, 22 individuals showed post-traumatic stress disorder (PTSD) symptoms and 53 reported having experienced childhood trauma. Men reported a significantly higher prevalence of both sexual concerns and dysfunctional sexual behavior compared with women.
› Verified 3 days ago
Barbara J Backus, N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1650 S 41st St, Manitowoc, WI 54220 Phone: 920-320-4500 Fax: 920-682-9378 | |
Jessica L Lietzan, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1650 S 41st St, Manitowoc, WI 54220 Phone: 920-320-2436 | |
Veronica Mcfarlane, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1650 S 41st St, Manitowoc, WI 54220 Phone: 920-320-2436 | |
Brenda Stallbaum, APNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 339 Reed Ave, Manitowoc, WI 54220 Phone: 920-320-8600 | |
Angela R Vandewettering, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1111 Bayshore Dr, Manitowoc, WI 54220 Phone: 920-682-6376 | |
Andrew Allen Malkowski, APNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 926 S 8th St, Manitowoc, WI 54220 Phone: 920-683-4230 Fax: 920-683-4902 | |
Nicole Amber Meissner, AGNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2409 S Alverno Rd, Manitowoc, WI 54220 Phone: 920-901-4420 Fax: 920-682-4243 |